Ploeger Hilde E, Bus Sicco A, Brehm Merel-Anne, Nollet Frans
Department of Rehabilitation Medicine, Amsterdam University Medical Center, Amsterdam Movement Sciences, University of Amsterdam, Amsterdam, the Netherlands -
Department of Rehabilitation Medicine, Amsterdam University Medical Center, Amsterdam Movement Sciences, University of Amsterdam, Amsterdam, the Netherlands.
Eur J Phys Rehabil Med. 2020 Oct;56(5):575-584. doi: 10.23736/S1973-9087.20.06020-7. Epub 2020 May 26.
Dorsiflexion-restricting ankle-foot orthoses (DR-AFOs) are often prescribed in polio survivors with calf muscle weakness to reduce or solve gait problems. However, orthoses are sometimes not being used and/or users are dissatisfied with the usability.
To compare the usability of custom-made DR-AFOs provided in clinical care between users and discontinued users who have calf muscle weakness due to polio.
Cross-sectional survey.
Outpatient post-polio university hospital clinic in the Netherlands.
All polio survivors with calf muscle weakness, provided with a DR-AFO between 2004 and 2015 in our outpatient clinic.
DR-AFO use and usability according to the ISO 9241-11 standard were evaluated with a questionnaire sent out by postal mail.
Forty of 57 questionnaires were returned. Five respondents did not fulfil the eligibility criteria. DR-AFO use among the 35 eligible respondents was 74%. Compared to discontinued users, users were significantly more often male (users: 16 of 26 vs. discontinued users: 0 of 9, P=0.001), more limited in their walking ability without DR-AFO (P=0.007), perceived more effectiveness, both overall (P=0.001) and on their personal goals of use (P=0.006), and were more satisfied with orthosis-related aspects (P=0.011), such as comfort.
Almost three quarters of the polio survivors used their orthosis. Use was related to several aspects of usability, indicating that it is important to consider usability in the prescription process of DR-AFOs for polio survivors with calf muscle weakness.
When prescribing DR-AFOs, it is important to consider that the orthosis is most likely used when the experienced walking problems are large and the DR-AFO reduces these problems. We recommend discussing the patient's personal goals for DR-AFO use and the anticipated improvement on the individual's walking problems as well as possible hindrance of the orthosis during daily life activities. Furthermore, providers may need to pay extra attention to females and should particularly take care that the experienced fit and comfort are satisfactory. Incorporating these suggestions in clinical practice may further improve DR-AFO use among polio survivors with calf muscle weakness.
对于患有小腿肌肉无力的脊髓灰质炎幸存者,常开具限制背屈的踝足矫形器(DR-AFO)以减轻或解决步态问题。然而,矫形器有时未被使用,和/或使用者对其可用性不满意。
比较在临床护理中提供的定制DR-AFO在因脊髓灰质炎导致小腿肌肉无力的使用者和停用者之间的可用性。
横断面调查。
荷兰一家大学医院的脊髓灰质炎门诊。
2004年至2015年期间在我们门诊接受DR-AFO的所有患有小腿肌肉无力的脊髓灰质炎幸存者。
根据ISO 9241-11标准,通过邮寄问卷评估DR-AFO的使用情况和可用性。
57份问卷中返回了40份。5名受访者不符合入选标准。35名符合条件的受访者中DR-AFO的使用率为74%。与停用者相比,使用者中男性比例显著更高(使用者:26人中有16人,停用者:9人中有0人,P=0.001),在不使用DR-AFO时行走能力受限更明显(P=0.007),总体上(P=0.001)以及在个人使用目标方面(P=0.006)都感觉更有效,并且对与矫形器相关的方面(如舒适度,P=0.011)更满意。
近四分之三的脊髓灰质炎幸存者使用了他们的矫形器。使用情况与可用性的几个方面相关,这表明在为患有小腿肌肉无力的脊髓灰质炎幸存者开具DR-AFO的处方过程中考虑可用性很重要。
开具DR-AFO时,重要的是要考虑到当经历的行走问题严重且DR-AFO能减轻这些问题时,矫形器最有可能被使用。我们建议讨论患者使用DR-AFO的个人目标以及对其行走问题的预期改善,以及日常生活活动中矫形器可能带来的阻碍。此外,提供者可能需要格外关注女性,尤其要确保所体验到的贴合度和舒适度令人满意。将这些建议纳入临床实践可能会进一步提高患有小腿肌肉无力的脊髓灰质炎幸存者对DR-AFO的使用率。